๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

21 recruiting trials

for Primary Cutaneous Lymphoma

Local Registry of Primary Cutaneous T-cell Lymphomas NCT07160023n/a1 site๐Ÿ“ Pavia Fondazione IRCCS Policlinico San Matteo di Pavia Q702 for the Treatment of Patients With Hematologic Malignancies NCT06712810Phase 12 sites๐Ÿ“ Scottsdale๐Ÿ“ Rochester Mayo Clinic ยท Tests: Axl/Mer/CSF1R Inhibitor Q702, Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Computed Tomography TreAtments and outComes in paTients With prImary CutAneous Lymphoma NCT05518851n/a5 sites๐Ÿ“ Beijing๐Ÿ“ Guandong๐Ÿ“ Nanjing Peking University First Hospital Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma NCT07356245Phase 21 site๐Ÿ“ Columbus Jonathan Brammer ยท Tests: Ruxolitinib, Positron emission tomography-computed tomography, Bone Marrow Biopsy, Biopsy Procedure, Biospecimen Collecโ€ฆ Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy NCT06834373Phase 27 sites๐Ÿ“ Scottsdale๐Ÿ“ Jacksonville๐Ÿ“ Albert Lea Mayo Clinic ยท Tests: Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Chimeric Antigen Receptor T-Cell Therapy, Computed โ€ฆ JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas NCT06716658Phase 22 sites๐Ÿ“ Tianjin๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: JAK1 Inhibitor Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma NCT04234048Phase 110 sites๐Ÿ“ Scottsdale๐Ÿ“ Duarte๐Ÿ“ Los Angeles SciTech Development, Inc. ยท Tests: Fenretinide Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies NCT05544968Phase 11 site๐Ÿ“ Milwaukee Medical College of Wisconsin ยท Tests: anti-CD30 Bispecific Antibody-armed anti-CD3-Activated Autologous T-cells (CD30 biAb-AATC), GM-CSF A Vaccine (VSV-hIFNฮฒ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma NCT03017820Phase 12 sites๐Ÿ“ Scottsdale๐Ÿ“ Rochester Mayo Clinic ยท Tests: Biopsy Procedure, Biospecimen Collection, Bone Marrow Biopsy, Computed Tomography, Cyclophosphamide A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL NCT06854653Phase 215 sites๐Ÿ“ Duarte๐Ÿ“ Irvine๐Ÿ“ New Haven Prescient Therapeutics, Ltd. ยท Tests: PTX-100 Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research NCT00177268n/a1 site๐Ÿ“ Pittsburgh University of Pittsburgh ยท Tests: Blood draw, skin biopsy or urine collection A Registry for People With T-cell Lymphoma NCT05978141n/a26 sites๐Ÿ“ Duarte๐Ÿ“ San Diego๐Ÿ“ San Francisco Memorial Sloan Kettering Cancer Center ยท Tests: Optional Blood Sample and Nail Sample Study of SGR-1505 in Mature B-Cell Neoplasms NCT05544019Phase 136 sites๐Ÿ“ Gilbert๐Ÿ“ Newark๐Ÿ“ Pompano Beach Schrรถdinger, Inc. ยท Tests: SGR-1505 Amping up With PemJAK NCT07283822Phase 21 site๐Ÿ“ New York Seda S. Tolu ยท Tests: Ruxolitinib, Pembrolizumab ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome NCT02848274n/a13 sites๐Ÿ“ Duarte๐Ÿ“ Palo Alto๐Ÿ“ Iowa City Stanford University Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma NCT04848064Phase 11 site๐Ÿ“ Columbus John Reneau ยท Tests: Cyclophosphamide, Fludarabine, Mogamulizumab, Natural Killer Cell Therapy, Quality-of-Life Assessment Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma NCT04930653Phase 23 sites๐Ÿ“ Scottsdale๐Ÿ“ Duarte๐Ÿ“ Atlanta City of Hope Medical Center ยท Tests: Extracorporeal Photopheresis, Mogamulizumab, Quality-of-Life Assessment, Questionnaire Administration Registry of Older Patients With Cancer NCT01137825n/a7 sites๐Ÿ“ Boone๐Ÿ“ Chapel Hill๐Ÿ“ Greenville UNC Lineberger Comprehensive Cancer Center Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer NCT01137643n/a1 site๐Ÿ“ Chapel Hill UNC Lineberger Comprehensive Cancer Center ยท Tests: biologic sample preservation procedure, cytology specimen collection procedure A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas NCT05475925Phase 1, Phase 237 sites๐Ÿ“ Birmingham๐Ÿ“ Duarte๐Ÿ“ Irvine Dren Bio ยท Tests: DR-01 Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29 NCT04670874n/a1 site๐Ÿ“ Duarte City of Hope Medical Center ยท Tests: Quality-of-Life Assessment, Questionnaire Administration
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy